ITCI
Voloridge Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,093,738
| Closed | -$144M | – | 1440 |
|
|
2025
Q1 | $144M | Buy |
+1,093,738
| New | +$144M | 0.53% | 21 |
|
|
2023
Q4 | – | Sell |
-49,887
| Closed | -$2.6M | – | 1543 |
|
|
2023
Q3 | $2.6M | Buy |
+49,887
| New | +$2.6M | 0.01% | 850 |
|
|
2022
Q3 | – | Sell |
-92,506
| Closed | -$5.28M | – | 1653 |
|
|
2022
Q2 | $5.28M | Buy |
+92,506
| New | +$5.28M | 0.03% | 653 |
|
|
2020
Q4 | – | Sell |
-29,078
| Closed | -$746K | – | 1624 |
|
|
2020
Q3 | $746K | Buy |
+29,078
| New | +$746K | 0.01% | 1015 |
|
|
2020
Q2 | – | Sell |
-45,043
| Closed | -$692K | – | 1554 |
|
|
2020
Q1 | $692K | Sell |
45,043
-66,462
| -60% | -$1.02M | 0.02% | 616 |
|
|
2019
Q4 | $3.83M | Buy |
111,505
+76,139
| +215% | +$2.61M | 0.07% | 340 |
|
|
2019
Q3 | $264K | Buy |
+35,366
| New | +$264K | ﹤0.01% | 955 |
|
|
2015
Q4 | – | Sell |
-50,270
| Closed | -$2.01M | – | 328 |
|
|
2015
Q3 | $2.01M | Buy |
+50,270
| New | +$2.01M | 0.09% | 179 |
|